The ICR responds to the FDA approval of olaparib for women with BRCA-mutant advanced breast cancer 12 Jan 2018 The Institute of Cancer Research, London, strongly welcomes the news that olaparib has been approved by the US Food and Drug Administration (FDA) for patients with advanced breast cancer. Find out more Show/Hide
European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer 22 Nov 2017 The prostate cancer drug abiraterone has been approved by the European Medicines Agency in combination with standard hormone therapy for use as a first-line treatment for advanced prostate cancer. Find out more Show/Hide
Seize chance to close EU loophole in childhood cancer treatments, say cancer experts 09 Mar 2017 Cancer treatments are not being trialled in children because of outdated European regulations which are in urgent need of reform, say cancer experts. Find out more Show/Hide
Our joint letter calling for reform of European regulations on clinical trials in children 09 Mar 2017
Statement in response to the European Medicines Agency's recommendation for approval of olaparib 24 Oct 2014